ARCHIVES

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

NCCS Changes Web Domain; NCCN Plans Clinical Trials Network

June 7, 2002

Sen. Specter Vows to “Stay and Fight” For Health, Education, On Subcommittee.

February 11, 2005

NCAB Subcommittee Worries About Board’s Makeup

January 19, 1979

Other Institutes Fare Well With ’77 Appropriations

August 20, 1976

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993